© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
BD Onclarity Added to ASCCP Guidelines: What It Means
May 05, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Multitarget Stool DNA Testing Outperforms FIT/FOBT for Completed Follow-up Colonoscopy in CRC-Vulnerable Populations
May 05, 2025
DDW 2025. Follow-up colonoscopy after a positive stool-based test was superior among adults aged 45-49 and across diverse populations whose original test was mt-sDNA.
Marschall Runge, MD PhD, Shares Thoughts on the Trajectory of Measles in the US
May 05, 2025
Measles, declared eradicated in the US 25years ago, has infected 900 Americans and is responsible for 3 deaths of children younger than age 5. How did we get here?
PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD
May 02, 2025
ACP 2025: Dr Fakorede outlines PAD risk amplifiers, polyvascular disease connections, and when to screen using ABI, TBI, or exercise testing in high-risk patients.
AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma
May 02, 2025
The KALOS and LOGOS registration trials in patients with uncontrolled asthma compared the triple fixed dose BGF with dual combination therapy.
The Role of Extended HPV Genotyping In Managing High Risk Patients
May 02, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds
May 02, 2025
Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.
Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates
May 02, 2025
A mail campaign targeting adults with chronic conditions as well as their GPs increased the number receiving at least 1 shot by 9.5 percentage points.
Peripheral Artery Disease in Primary Care: Expert Insights on Recognition & Risk Factors
May 01, 2025
ACP 2025: Foluso Fakorede, MD, discusses the importance of recognizing and screening for peripheral artery disease in primary care.
FDA Approves STS101 (Dihydroergotamine) Nasal Powder for Acute Treatment of Migraine
May 01, 2025
The only approved DHE nasal powder addresses persistent limitations of existing DHE formulations, including liquid nasal sprays and injectables, Satsuma stated.